Content area
Abstract
Summary Telomere length decreases with age and is associated with osteoblast senescence. In 2,150 unselected women, leukocyte telomere length was significantly correlated with bone mineral density. Clinical osteoporosis was associated with shorter telomeres, suggesting that telomere length can be used as a marker of bone aging. Introduction The length of telomeres in proliferative cells diminishes with age. Telomere shortening and telomerase activity have been linked to in vitro osteoblast senescence and to increased secretion of pro-inflammatory cytokines. We explored whether bone mineral density correlates with telomere length in leukocytes. Materials and methods The relationship between leukocyte telomere length, bone mineral density (BMD) and osteoporosis (as defined by the World Health Organization) was examined in a cohort of 2,150 women from a population-based twin cohort aged 18-79. Results After adjusting for age, body mass index, menopausal status, smoking, hormone replacement therapy status, telomere length was positively correlated with BMD of the spine (p<0.005), forearm (p<0.013), but not the femoral neck (p<0.06). Longer telomeres were associated with reduced the risk of clinical OP at two or more sites (odds ratio=0.594 95% CI 0.42–0.84 p<0.003) and in women over the age of 50, clinical osteoporosis was associated with 117 bp shorter telomere length (p<0.02) equivalent to 5.2 years of telomeric aging. Conclusions Shortened leukocyte telomere length is independently associated with a decrease in BMD and the presence of osteoporosis in women. Our data provide evidence that leukocyte telomere length could be a marker of biological aging of bone. [PUBLICATION ABSTRACT]